Spatial Domain
Spatial Domain (Tier 1)
2,069 ready
| Sample | Organ | Disease state | Cells | Dominant compartment ?Largest Tier 1 spatial domain by sample fraction; this is a biological neighborhood label, not a row-count summary. | Domain share | Purity | Diversity |
|---|---|---|---|---|---|---|---|
| NSCLC_38242124__IMC__178_B2,3 | Lung | Primary cancer | 2,231 | Tumor/Malignant | 39.4% | 0.89 | 0.38 |
| NSCLC_38242124__IMC__178_B2,4 | Lung | Primary cancer | 1,722 | Other | 26.8% | 0.56 | 0.80 |
| NSCLC_38242124__IMC__178_B2,5 | Lung | Primary cancer | 2,518 | Tumor/Malignant | 37.2% | 0.97 | 0.13 |
| NSCLC_38242124__IMC__178_B2,6 | Lung | Primary cancer | 1,446 | Tumor/Malignant | 29.2% | 0.52 | 0.90 |
| NSCLC_38242124__IMC__178_B2,7 | Lung | Primary cancer | 420 | Other | 49.3% | 0.35 | 0.90 |
| NSCLC_38242124__IMC__178_B2,8 | Lung | Primary cancer | 3,794 | Tumor/Malignant | 58.5% | 1.00 | 0.03 |
| NSCLC_38242124__IMC__178_B2,9 | Lung | Primary cancer | 2,293 | Tumor/Malignant | 61.9% | 0.97 | 0.12 |
| NSCLC_38242124__IMC__178_B3,1 | Lung | Primary cancer | 1,927 | Other | 36.9% | 0.35 | 1.04 |
| NSCLC_38242124__IMC__178_B3,10 | Lung | Primary cancer | 3,255 | Tumor/Malignant | 73.9% | 0.96 | 0.12 |
| NSCLC_38242124__IMC__178_B3,11 | Lung | Primary cancer | 2,170 | Tumor/Malignant | 42.9% | 0.84 | 0.46 |
| NSCLC_38242124__IMC__178_B3,12 | Lung | Primary cancer | 2,679 | Tumor/Malignant | 49.9% | 0.55 | 0.81 |
| NSCLC_38242124__IMC__178_B3,13 | Lung | Primary cancer | 2,177 | Immune | 30.2% | 0.31 | 1.03 |
| NSCLC_38242124__IMC__178_B3,14 | Lung | Primary cancer | 1,286 | Other | 25.0% | 0.74 | 0.55 |
| NSCLC_38242124__IMC__178_B3,15 | Lung | Primary cancer | 769 | Stromal | 28.2% | 0.70 | 0.62 |
| NSCLC_38242124__IMC__178_B3,16 | Lung | Primary cancer | 2,681 | Other | 24.2% | 0.67 | 0.68 |
| NSCLC_38242124__IMC__178_B3,17 | Lung | Primary cancer | 3,128 | Tumor/Malignant | 47.3% | 0.93 | 0.23 |
| NSCLC_38242124__IMC__178_B3,18 | Lung | Primary cancer | 2,368 | Tumor/Malignant | 57.9% | 0.99 | 0.06 |
| NSCLC_38242124__IMC__178_B3,2 | Lung | Primary cancer | 1,965 | Tumor/Malignant | 67.5% | 0.96 | 0.18 |
| NSCLC_38242124__IMC__178_B3,3 | Lung | Primary cancer | 1,432 | Tumor/Malignant | 27.5% | 0.95 | 0.17 |
| NSCLC_38242124__IMC__178_B3,4 | Lung | Primary cancer | 3,426 | Tumor/Malignant | 30.6% | 0.94 | 0.20 |
Spatial Domain (Tier 2)
2,069 ready
| Sample | Organ | Disease state | Cells | Dominant compartment ?Largest Tier 1 spatial domain by sample fraction; this is a biological neighborhood label, not a row-count summary. | Domain share | Purity | Diversity |
|---|---|---|---|---|---|---|---|
| NSCLC_38242124__IMC__178_B2,3 | Lung | Primary cancer | 2,231 | Tumor/Malignant | 28.9% | 0.93 | 0.25 |
| NSCLC_38242124__IMC__178_B2,4 | Lung | Primary cancer | 1,722 | Stromal | 27.6% | 0.32 | 1.10 |
| NSCLC_38242124__IMC__178_B2,5 | Lung | Primary cancer | 2,518 | Tumor/Malignant | 35.4% | 0.97 | 0.10 |
| NSCLC_38242124__IMC__178_B2,6 | Lung | Primary cancer | 1,446 | Other | 35.7% | 0.36 | 1.01 |
| NSCLC_38242124__IMC__178_B2,7 | Lung | Primary cancer | 420 | Other | 50.2% | 0.35 | 1.01 |
| NSCLC_38242124__IMC__178_B2,8 | Lung | Primary cancer | 3,794 | Tumor/Malignant | 52.5% | 0.99 | 0.04 |
| NSCLC_38242124__IMC__178_B2,9 | Lung | Primary cancer | 2,293 | Tumor/Malignant | 50.0% | 0.97 | 0.11 |
| NSCLC_38242124__IMC__178_B3,1 | Lung | Primary cancer | 1,927 | Other | 33.0% | 0.36 | 1.03 |
| NSCLC_38242124__IMC__178_B3,10 | Lung | Primary cancer | 3,255 | Tumor/Malignant | 59.9% | 0.99 | 0.04 |
| NSCLC_38242124__IMC__178_B3,11 | Lung | Primary cancer | 2,170 | Tumor/Malignant | 30.9% | 0.53 | 0.77 |
| NSCLC_38242124__IMC__178_B3,12 | Lung | Primary cancer | 2,679 | Tumor/Malignant | 37.6% | 0.56 | 0.76 |
| NSCLC_38242124__IMC__178_B3,13 | Lung | Primary cancer | 2,177 | Other | 25.2% | 0.29 | 1.07 |
| NSCLC_38242124__IMC__178_B3,14 | Lung | Primary cancer | 1,286 | Other | 25.0% | 0.75 | 0.59 |
| NSCLC_38242124__IMC__178_B3,15 | Lung | Primary cancer | 769 | Stromal | 31.2% | 0.72 | 0.62 |
| NSCLC_38242124__IMC__178_B3,16 | Lung | Primary cancer | 2,681 | Other | 21.4% | 0.70 | 0.72 |
| NSCLC_38242124__IMC__178_B3,17 | Lung | Primary cancer | 3,128 | Tumor/Malignant | 41.9% | 0.95 | 0.18 |
| NSCLC_38242124__IMC__178_B3,18 | Lung | Primary cancer | 2,368 | Tumor/Malignant | 52.2% | 0.99 | 0.07 |
| NSCLC_38242124__IMC__178_B3,2 | Lung | Primary cancer | 1,965 | Tumor/Malignant | 58.2% | 0.97 | 0.12 |
| NSCLC_38242124__IMC__178_B3,3 | Lung | Primary cancer | 1,432 | Tumor/Malignant | 27.2% | 0.96 | 0.16 |
| NSCLC_38242124__IMC__178_B3,4 | Lung | Primary cancer | 3,426 | Tumor/Malignant | 35.0% | 0.91 | 0.26 |
Spatial Domain (Tier 3)
2,069 ready
| Sample | Organ | Disease state | Cells | Dominant compartment ?Largest Tier 1 spatial domain by sample fraction; this is a biological neighborhood label, not a row-count summary. | Domain share | Purity | Diversity |
|---|---|---|---|---|---|---|---|
| NSCLC_38242124__IMC__178_B2,3 | Lung | Primary cancer | 2,231 | Tumor/Malignant cell | 41.7% | 0.87 | 0.42 |
| NSCLC_38242124__IMC__178_B2,4 | Lung | Primary cancer | 1,722 | Other | 23.9% | 0.57 | 0.85 |
| NSCLC_38242124__IMC__178_B2,5 | Lung | Primary cancer | 2,518 | Tumor/Malignant cell | 37.3% | 0.97 | 0.13 |
| NSCLC_38242124__IMC__178_B2,6 | Lung | Primary cancer | 1,446 | Fibroblast | 29.7% | 0.36 | 1.04 |
| NSCLC_38242124__IMC__178_B2,7 | Lung | Primary cancer | 420 | Other | 49.8% | 0.32 | 1.10 |
| NSCLC_38242124__IMC__178_B2,8 | Lung | Primary cancer | 3,794 | Tumor/Malignant cell | 65.4% | 0.99 | 0.05 |
| NSCLC_38242124__IMC__178_B2,9 | Lung | Primary cancer | 2,293 | Tumor/Malignant cell | 62.4% | 0.97 | 0.13 |
| NSCLC_38242124__IMC__178_B3,1 | Lung | Primary cancer | 1,927 | Other | 28.3% | 0.58 | 0.88 |
| NSCLC_38242124__IMC__178_B3,10 | Lung | Primary cancer | 3,255 | Tumor/Malignant cell | 73.5% | 0.96 | 0.12 |
| NSCLC_38242124__IMC__178_B3,11 | Lung | Primary cancer | 2,170 | Fibroblast | 34.6% | 0.50 | 0.80 |
| NSCLC_38242124__IMC__178_B3,12 | Lung | Primary cancer | 2,679 | Tumor/Malignant cell | 38.2% | 0.81 | 0.55 |
| NSCLC_38242124__IMC__178_B3,13 | Lung | Primary cancer | 2,177 | Fibroblast | 27.0% | 0.52 | 0.95 |
| NSCLC_38242124__IMC__178_B3,14 | Lung | Primary cancer | 1,286 | Tumor/Malignant cell | 29.0% | 0.88 | 0.35 |
| NSCLC_38242124__IMC__178_B3,15 | Lung | Primary cancer | 769 | Fibroblast | 38.8% | 0.87 | 0.34 |
| NSCLC_38242124__IMC__178_B3,16 | Lung | Primary cancer | 2,681 | Fibroblast | 24.8% | 0.65 | 0.75 |
| NSCLC_38242124__IMC__178_B3,17 | Lung | Primary cancer | 3,128 | Tumor/Malignant cell | 47.4% | 0.92 | 0.24 |
| NSCLC_38242124__IMC__178_B3,18 | Lung | Primary cancer | 2,368 | Tumor/Malignant cell | 57.9% | 0.99 | 0.06 |
| NSCLC_38242124__IMC__178_B3,2 | Lung | Primary cancer | 1,965 | Tumor/Malignant cell | 68.5% | 0.95 | 0.19 |
| NSCLC_38242124__IMC__178_B3,3 | Lung | Primary cancer | 1,432 | Tumor/Malignant cell | 27.9% | 0.96 | 0.19 |
| NSCLC_38242124__IMC__178_B3,4 | Lung | Primary cancer | 3,426 | Tumor/Malignant cell | 48.2% | 0.88 | 0.32 |